Waymo and Uber reached a settlement Friday to end their blockbuster trade secrets fight over self-driving car technology, capping off a year of contentious discovery disputes, shocking revelations and numerous delays. Here's a play-by-play of how we got here.
A federal judge has dismissed four patents from LG Philips LCD Co.’s four-year-old lawsuit against Chunghwa Picture Tubes Ltd., bringing an end to a bitter dispute over side-mounts for LDC modules.
Pfizer Inc. has won yet another battle in its war against Ranbaxy Laboratories over its generic version of blockbuster cholesterol drug Lipitor, after the Austrian Patent Office upheld Pfizer’s basic patent for the drug.
Reed Smith LLP stands to significantly beef up its intellectual property practice with the acquisition of a Chicago-based mid-sized law firm, if the deal is approved by both firms’ shareholders.
The U.S. Court of Appeals for the Federal Circuit on Monday reversed a lower court ruling that Medrad Inc.’s patent for MRI technology was invalid because it failed to file supplemental reissue declarations while seeking the reissue of its patent.
Dr. Lian Ouyang has joined Fish & Richardson P.C.’s Boston office as a technology specialist, continuing the IP boutique’s aggressive efforts to expand its turf in the IP industry.
After years of wrangling over licenses, Gemstar-TV Guide International Inc. has hit Digeo Inc. with a lawsuit for allegedly infringing its patented technology for online television program guides.
Biotechnology company Enzo Biochem Inc. received a favorable claim-construction ruling in its patent infringement suit against rival Applera Corp., but the judge ruled against the company on one of its patents for DNA-detecting technology.
Virgin Mobile USA settled an outstanding patent dispute with Freedom Wireless Inc. on Friday, becoming the latest telecommunications company to end its legal woes over prepaid phone services.
The New Jersey Supreme Court has come down against the use of a popular corporate tax shelter, ruling that companies doing business in the state cannot protect profits from state corporate income tax by using out-of-state subsidiaries to hold their intellectual property.
With Japan the leader in patent applications worldwide, and its neighbors increasing their IP savvy, statistics confirm that Asia is on the move, according to a report released by the World Intellectual Property Organization (WIPO).
Blocking two proposed generic versions of an antipsychotic drug, a New Jersey district court has affirmed the validity and enforceability of a Johnson & Johnson unit’s patent for Risperdal.
A federal judge has signed off on the settlement agreement over a generic version of painkiller OxyContin between generic drug maker Teva Pharmaceuticals Industries Ltd. and Purdue Pharma LP, bringing pending litigation to an end.
Unwilling to get involved in the type of legal scuffle from which fellow tech company Google Corp. just emerged, Microsoft’s Belgian MSN division has already started communicating with Belgian copyright group Copiepresse.
Visual communication company StarBak Communications Inc. settled two patent infringement lawsuits against Norwegian rival Tandberg ASA, entering into a new agreement for the licensing of video streaming and archiving technologies.
Five years after a similar ruling in the United States, the Supreme Court of Canada has affirmed the rights of freelancers in Canada by ruling that newspapers and magazines must seek permission before putting works in online databases.
A proposal from the U.S. Patent and Trademark Office to create a so-called “suite” of patent products has raised concerns that the agency is sacrificing long-term quality to meet short-term production goals.
Johnson & Johnson has asked a New Jersey district judge to prevent the launch of copycat versions of its lucrative epilepsy drug Topamax.
In a setback for the company whose pork product has become a synonym for unsolicited e-mail, Hormel Foods Corp. lost a bid in the European Union to trademark the word “spam.”
Looking to protect its popular first aid antibiotic ointment Neosporin, Pfizer Inc. has filed a trademark suit against a generic pharmaceutical company alleging that its packaging for its ointments is too similar.
A small chip maker has filed a patent infringement lawsuit against microprocessor giant Intel Corp., alleging the company’s most popular and lucrative products are infringing its patents for power-saving technology.